-
Je něco špatně v tomto záznamu ?
Formulation of hyaluronan grafted with dodecanoic acid as a potential ophthalmic treatment
G. Huerta-Ángeles, F. Ondreáš, M. Brandejsová, K. Kopecká, H. Vagnerová, J. Kulhánek, T. Drmota
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články
- MeSH
- buněčné linie keratinocytů HaCaT MeSH
- buňky NIH 3T3 MeSH
- hydrofobní a hydrofilní interakce MeSH
- kyselina hyaluronová chemie MeSH
- kyseliny laurové chemie MeSH
- lidé MeSH
- molekulová hmotnost MeSH
- muciny chemie MeSH
- myši MeSH
- povrchové napětí účinky léků MeSH
- příprava léků metody MeSH
- reologie metody MeSH
- syndromy suchého oka farmakoterapie MeSH
- viabilita buněk účinky léků MeSH
- viskozita účinky léků MeSH
- zvířata MeSH
- zvlhčující oční kapky chemie farmakologie terapeutické užití MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
This work concerns the chemical modification of medium molecular weight hyaluronan for ophthalmic applications. The synthesis of amphiphilic HA with dodecanoyl moities was carried out under mild aqueous conditions. Perfect control of the degree of substitution was obtained by varying the molar ratio of activated fatty acid used in the reaction feed. Moreover, the preparation of the derivatives was optimized to achieve the desired degree of substitution (DS = 9.0 ± 0.2 %). The prepared hyaluronan derivatives were water-soluble and exhibited self-associating properties (amphiphilicity). The structure of the prepared derivatives was elucidated by NMR spectroscopy, rheology, turbidity, SEC-MALLS, and gas chromatography (GC). The hydrophobic moieties increase the solution viscosity by physical crosslinking. Low concentration of HAC12 is needed to prepare highly viscous solutions with potential use for ophthalmic applications. Amphiphilic HA kept the biocompatibility of hyaluronan. The degree of substitution and Mw of the amphiphilic HA controls the sterilization by filtration. The protection against desiccation was tested using human keratinocytes (HaCaT) cells lines.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21019976
- 003
- CZ-PrNML
- 005
- 20210830101555.0
- 007
- ta
- 008
- 210728s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.carbpol.2020.116578 $2 doi
- 035 __
- $a (PubMed)32747245
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Huerta-Ángeles, Gloria $u Contipro a.s., Dolni Dobrouč 401, 561 02 Dolni Dobrouč, Czech Republic. Electronic address: huerta-angeles@contipro.com
- 245 10
- $a Formulation of hyaluronan grafted with dodecanoic acid as a potential ophthalmic treatment / $c G. Huerta-Ángeles, F. Ondreáš, M. Brandejsová, K. Kopecká, H. Vagnerová, J. Kulhánek, T. Drmota
- 520 9_
- $a This work concerns the chemical modification of medium molecular weight hyaluronan for ophthalmic applications. The synthesis of amphiphilic HA with dodecanoyl moities was carried out under mild aqueous conditions. Perfect control of the degree of substitution was obtained by varying the molar ratio of activated fatty acid used in the reaction feed. Moreover, the preparation of the derivatives was optimized to achieve the desired degree of substitution (DS = 9.0 ± 0.2 %). The prepared hyaluronan derivatives were water-soluble and exhibited self-associating properties (amphiphilicity). The structure of the prepared derivatives was elucidated by NMR spectroscopy, rheology, turbidity, SEC-MALLS, and gas chromatography (GC). The hydrophobic moieties increase the solution viscosity by physical crosslinking. Low concentration of HAC12 is needed to prepare highly viscous solutions with potential use for ophthalmic applications. Amphiphilic HA kept the biocompatibility of hyaluronan. The degree of substitution and Mw of the amphiphilic HA controls the sterilization by filtration. The protection against desiccation was tested using human keratinocytes (HaCaT) cells lines.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a viabilita buněk $x účinky léků $7 D002470
- 650 _2
- $a příprava léků $x metody $7 D004339
- 650 _2
- $a syndromy suchého oka $x farmakoterapie $7 D015352
- 650 _2
- $a buněčné linie keratinocytů HaCaT $7 D000084282
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kyselina hyaluronová $x chemie $7 D006820
- 650 _2
- $a hydrofobní a hydrofilní interakce $7 D057927
- 650 _2
- $a kyseliny laurové $x chemie $7 D007850
- 650 _2
- $a zvlhčující oční kapky $x chemie $x farmakologie $x terapeutické užití $7 D065346
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a molekulová hmotnost $7 D008970
- 650 _2
- $a muciny $x chemie $7 D009077
- 650 _2
- $a buňky NIH 3T3 $7 D041681
- 650 _2
- $a reologie $x metody $7 D012212
- 650 _2
- $a povrchové napětí $x účinky léků $7 D013500
- 650 _2
- $a viskozita $x účinky léků $7 D014783
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Ondreáš, František $u Contipro a.s., Dolni Dobrouč 401, 561 02 Dolni Dobrouč, Czech Republic
- 700 1_
- $a Brandejsová, Martina $u Contipro a.s., Dolni Dobrouč 401, 561 02 Dolni Dobrouč, Czech Republic
- 700 1_
- $a Kopecká, Kateřina $u Contipro a.s., Dolni Dobrouč 401, 561 02 Dolni Dobrouč, Czech Republic
- 700 1_
- $a Vagnerová, Hana $u Contipro a.s., Dolni Dobrouč 401, 561 02 Dolni Dobrouč, Czech Republic
- 700 1_
- $a Kulhánek, Jaromir $u Contipro a.s., Dolni Dobrouč 401, 561 02 Dolni Dobrouč, Czech Republic
- 700 1_
- $a Drmota, Tomáš $u Contipro a.s., Dolni Dobrouč 401, 561 02 Dolni Dobrouč, Czech Republic
- 773 0_
- $w MED00006149 $t Carbohydrate polymers $x 1879-1344 $g Roč. 246, č. - (2020), s. 116578
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32747245 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830101555 $b ABA008
- 999 __
- $a ok $b bmc $g 1690713 $s 1140422
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 246 $c - $d 116578 $e 20200612 $i 1879-1344 $m Carbohydrate polymers $n Carbohydr Polym $x MED00006149
- LZP __
- $a Pubmed-20210728